Adderall Capsule, Extended Release
Product Images NDC 54092-385

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Adderall (NDC 54092-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adderall Xr 01

This appears to be a chart or table showing dosages of dextroamphetamine and levoamphetamine, specifically Adderall XR and Adderall, at various times throughout the day. The dosages listed range from 10mg to 20mg and are administered once or twice a day. The chart also includes a time axis labeled in hours, up to 24 hours.*

FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

This text appears to include some gibberish text, and also some useful information about a prescription drug called ADDERALL XR®. The drug is described as a mixed salt of a single-entity amphetamine product, available in extended-release capsules with 100 capsules per package. The text also provides the manufacturer's name, Takeda Pharmaceuticals America, Inc., and their address in Lexington, MA. The drug is available only with a prescription.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

ADDERALL XR® is a registered trademark of Takeda Pharmaceuticals. The provided text appears to be a mix of random characters and numbers, and is not available for generating any useful descriptions.*

FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

This is a description of a drug called ADDERALL XR® which is a registered trademark of Takeda Pharmaceuticals USA., Inc. It comes in the form of mixed salts of a single-entity Amphetamine Product and is available in 100 capsules. The text also includes some numerical and symbol characters which might be related to dosage or quantity information. The drug is distributed by Takeda Pharmaceuticals America, Inc. However, the text does not provide much detail about the medical application or recommended dosage, making it difficult to provide a comprehensive description of the drug's benefits or risks.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

The text contains a mix of different information. It includes a string of alphanumeric characters and symbols, a few lines of seemingly random text, and a product trademark. Therefore, it is not possible to generate a useful description.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

This appears to be a description of a medication called ADDERALL XR, which is a registered trademark of Takeda Pharmaceuticals. The text includes information such as the dosage form (capsules), the manufacturer (Takeda Pharmaceuticals America, Inc.), and a prescription use only warning. The rest of the text appears to include product codes, dosage information, and possibly other pharmaceutical-related data.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.